The Cancer Genome Atlas database and Gene Expression Profile Interaction Analysis 2 results showed that SUCLG2 expression levels were significantly higher in GBM samples than in normal tissues (Figs. 1C, S1A). The gene discussed is SUCLG2; the disease is glioblastoma.